Distinct effector mechanisms in the development of autoimmune neuropathy versus diabetes in nonobese diabetic mice

被引:45
作者
Bour-Jordan, W [1 ]
Thompson, HL [1 ]
Bluestone, JA [1 ]
机构
[1] Univ Calif San Francisco, Ctr Diabet, Dept Med, San Francisco, CA 94143 USA
关键词
D O I
10.4049/jimmunol.175.9.5649
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
NOD mice deficient for the costimulatory molecule B7-2 (NOD-B7-2KO mice) are protected from autoimmune diabetes but develop a spontaneous autoimmune peripheral neuropathy that resembles human diseases Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. Similar observations have now been made in conventional NOD mice. We have shown previously that this disease was mediated by autoreactive T cells inducing demyelination in the peripheral nervous system. In this study, we analyzed the molecular pathways involved in the disease. Our data showed that neuropathy developed in the absence of perforin or fas, suggesting that classic cytotoxicity pathways were dispensable for nerve damage in NOD-137-2KO mice. In contrast, IFN-gamma played an obligatory role in the development of neuropathy as demonstrated by the complete protection from disease and infiltration in the nerves in NOD-137-2KO mice deficient for IFN-gamma. This result was consistent with the inflammatory phenotype of T cells infiltrating the peripheral nerves. Importantly, the relative role of perforin, fas, and IFN-gamma appears completely different in autoimmune diabetes vs neuropathy. Thus, there are sharp contrasts in the pathogenesis of autoimmune diseases targeting different tissues in the same NOD background.
引用
收藏
页码:5649 / 5655
页数:7
相关论文
共 56 条
  • [1] Role of cytokines in neurological disorders
    Aarli, JA
    [J]. CURRENT MEDICINAL CHEMISTRY, 2003, 10 (19) : 1931 - 1937
  • [2] Exogenous soluble tumor necrosis factor receptor type I ameliorates murine experimental autoimmune neuritis
    Bao, L
    Lindgren, JU
    Zhu, Y
    Ljunggren, HG
    Zhu, J
    [J]. NEUROBIOLOGY OF DISEASE, 2003, 12 (01) : 73 - 81
  • [3] Bao L, 2002, BRAIN PATHOL, V12, P420
  • [4] T-cell cytotoxicity of human Schwann cells:: TNFα promotes fasL-mediated apoptosis and IFNγ perforin-mediated lysis
    Bonetti, B
    Valdo, P
    Ossi, G
    De Toni, L
    Masotto, B
    Marconi, S
    Rizzuto, N
    Nardelli, E
    Moretto, G
    [J]. GLIA, 2003, 43 (02) : 141 - 148
  • [5] Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells
    Bour-Jordan, H
    Salomon, BL
    Thompson, HL
    Szot, GL
    Bernhard, MR
    Bluestone, JA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (07) : 979 - 987
  • [6] The role of Fas in autoimmune diabetes
    Chervonsky, AV
    Wang, Y
    Wong, FS
    Visintin, I
    Flavell, RA
    Janeway, CA
    Matis, LA
    [J]. CELL, 1997, 89 (01) : 17 - 24
  • [7] Schwann cell undergoes apoptosis during experimental allergic neuritis (EAN)
    Conti, G
    Scarpini, E
    Rostami, A
    Livraghi, S
    Baron, PL
    Pleasure, D
    Scarlato, G
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 161 (01) : 29 - 35
  • [8] Circulating tumor necrosis factor (TNF)-alpha and soluble TNF-alpha receptors in patients with Guillain-Barre syndrome
    Creange, A
    Belec, L
    Clair, B
    Raphael, JC
    Gherardi, RK
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1996, 68 (1-2) : 95 - 99
  • [9] T helper type 2 like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillain-Barre syndrome
    Dahle, C
    Ekerfelt, C
    Vrethem, M
    Samuelsson, M
    Ernerudh, J
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1997, 153 (01) : 54 - 60
  • [10] Elevated number of cells secreting transforming growth factor β in Guillain-Barre syndrome
    Dahle, C
    Kvarnström, M
    Ekerfelt, C
    Samuelsson, M
    Ernerudh, J
    [J]. APMIS, 2003, 111 (12) : 1095 - 1104